KASINGER JAMES R. (General Counsel and Secretary) sold 9.9% of their position (10.40K shares) of CRISPR THERAPEUTICS AG on the open market
Open‑market sale worth $626.5K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/24/2026ACC: 0001193125-26-401237
Officer· General Counsel and Secretary
Since Feb 2026
-10.40K
Net shares
Net seller
$626.5K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
10.40K acquired · 20.80K disposed
Non-Derivative Transactions2
Common Shares
Direct
Shares
+10.40K
Price / share
$13.62
Trade value
$141.65K
% of position
11.0%
9/22/2026
94.78K→105.18K
Common Shares
Direct
Shares
−10.40K
Price / share
$60.24
Trade value
$626.46K
% of position
9.9%
9/22/2026
105.18K→94.78K
Total
Net shares
+0.00
Net value
-$484.81K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 9/22/2026 | M · Option Exercise | +10.40K | $13.62 | $141.65K | 11.0% | 94.78K | 105.18K |
| Common Shares Direct | 9/22/2026 | S · Sale | −10.40K | $60.24 | $626.46K | 9.9% | 105.18K | 94.78K |
| Total | +0.00 | -$484.81K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Shares
10.40K shares
Shares
−10.40K
Strike price
13.62
Held after
83.23K
Exercisable
—
9/22/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Shares10.40K shares | 9/22/2026 | M · Option Exercise | −10.40K | 13.62 | — | 83.23K |